Ingevity CORP

Ingevity Corporation announced its second quarter 2026 financial results, showcasing a significant year-over-year improvement in net income and adjusted EBITDA, leading to an increased full-year financial outlook.

Ingevity Corporation has appointed Ryan Cotterman as its new Vice President and Chief Accounting Officer, effective June 22, 2026.

Ingevity announced its first quarter 2026 financial results, with net sales up 4% to $258.0 million, driven by pricing actions and favorable foreign exchange, while navigating divestitures and legal settlements.

Ingevity Corporation's annual stockholder meeting saw approval for an amendment to its 2025 Omnibus Incentive Plan, increasing available shares by 580,000.

Ingevity Corporation has finalized the divestiture of its Ozark Materials road markings business to PPG Industries for approximately $65 million in cash.

Ingevity amended and restated its credit facility, cutting total commitments to $750 million and extending the revolver maturity to March 26, 2031, while repaying $512.1 million of outstanding borrowings.

Ingevity Corporation's Q2 2026 results show a net sales decrease driven by divestitures, with segment performance varying across its business units.

Ingevity Corporation announced its first quarter 2026 financial results, highlighting a net sales increase driven by pricing and favorable foreign exchange, alongside progress in strategic divestitures.

Ingevity Corporation reported a significant improvement in net income for Q3 2025, driven by reduced losses from discontinued operations, despite flat net sales and a downward revision to its full-year outlook.

Ingevity Corporation reported a reduced net loss in Q2 2025, driven by strategic repositioning efforts and improved cash flow, despite a significant goodwill impairment in its Advanced Polymer Technologies segment.

Ingevity Corporation's Q1 2025 results show a mixed performance with decreased net sales offset by improved profitability in certain segments, leading to an adjusted full-year outlook reflecting industry forecasts.

Ingevity Corporation's Q3 2024 results reflect a net loss, impacted by restructuring charges and lower sales volumes, particularly in the Performance Chemicals segment.

Ingevity Corporation finalized its strategic portfolio review in 2025, divesting its industrial specialties and CTO refinery businesses, while reporting a net loss of $167.1 million for the year, impacted by significant impairment charges and legal expenses.

Ingevity Corporation reports a net loss of $430.3 million for 2024, driven by a goodwill impairment charge and restructuring activities, while announcing a strategic review of its industrial specialties product line.

Ingevity Corporation's 2023 annual report details a year of strategic repositioning, including a significant restructuring of its Performance Chemicals segment, alongside a review of its financial performance.

Ryan C. Fisher, SVP, Gen. Counsel & Secretary of Ingevity Corp, sold 2,709 shares of common stock on August 3, 2026.

Phillip John Platt, SVP, Chief Financial Officer of Ingevity Corp, reported a transaction in 3,294 shares of common stock on July 24, 2026.

Ingevity Corp's SVP, Gen. Counsel & Secretary, Ryan C. Fisher, reported transactions involving common stock, including shares withheld for taxes and shares purchased through an employee stock purchase plan.

Ingevity Corp. director J. Kevin Willis acquired 397 shares of common stock through a deferred compensation plan.

Ingevity Corp. director Francis David Segal acquired 328 shares of common stock through vested deferred stock units.

Ingevity Corp's VP, Chief Accounting Officer, Ryan Joseph Cotterman, was granted 2,063 restricted stock units under the company's 2025 Omnibus Incentive Plan.

Ingevity Corporation outlines its 2025 strategic transformation to a focused specialty materials company, reporting strong adjusted financial performance and a clear path for long-term value creation.

Ingevity Corporation entered into a cooperation agreement with Vision One Fund, LP, resulting in the appointment of F. David Segal to the Board of Directors and other mutual commitments.

Vision One Fund is soliciting proxies to elect its nominees to Ingevity's board, aiming to drive change, restore governance, and enhance capital allocation strategies.

Ingevity Corporation has filed its definitive proxy statement and is urging stockholders to vote for its nine director nominees on the WHITE proxy card at the upcoming Annual Meeting on April 30, 2025, amidst a proxy fight with Vision One.

Ingevity names David H. Li as its new CEO, reports exceeding analyst expectations with $363 million adjusted EBITDA for fiscal 2024, and progresses with its portfolio optimization strategy.

Ingevity Corporation appoints Michael N. Shukov as Senior Vice President and President of Advanced Polymer Technologies, effective March 12, 2025, to drive profitability and growth.

Wellington Management Group LLP and its affiliates have reported a beneficial ownership of 4.2% in Ingvity Corporation's common stock as of March 31, 2026.

Vanguard Capital Management has reported beneficial ownership of 5.26% of Ingevity Corp's common stock as of March 31, 2026.

Vanguard Portfolio Management has reported a beneficial ownership of 6.27% in Ingevity Corp's common stock as of March 31, 2026.

The Vanguard Group has reported a 0% beneficial ownership in Ingevity Corp following an internal realignment, disaggregating its reporting.

Victory Capital Management, Inc. has reported a passive beneficial ownership of 2.15% in Ingevity Corp, totaling 782,930 shares of common stock.

BlackRock, Inc. has filed an amended Schedule 13G, reporting a 15.5% beneficial ownership stake in Ingevity Corp's common stock as of March 31, 2025.